Dacomitinib Products | Cleanchem - Dacomitinib is a second-generation EGFR tyrosine kinase inhibitor used to treat non-small cell lung cancer (NSCLC) with EGFR mutations. It binds irreversibly to the receptor, blocking cell signaling pathways that promote tumor growth. Dacomitinib is taken orally and has shown improved progression-free survival compared to first-generation EGFR inhibitors.

Cat. No: CL-DMTB-NO-01

CAS No: NA

Mol. F: C24H24ClFN6O3

Mol. Wt: 498.9

Inv. Status: Custom Synthesis

Cat. No: CL-DMTB-NO-02

CAS No: NA

Mol. F: C24H24ClFN6O3

Mol. Wt: 498.94

Inv. Status: Custom Synthesis

Cat. No: CL-DMTB-NO-03

CAS No: NA

Mol. F: C15H11ClFN5O2

Mol. Wt: 347.73

Inv. Status: Custom Synthesis

Cat. No: CL-DMTB-NO-04

CAS No: NA

Mol. F: C19H15ClFN5O4

Mol. Wt: 431.805

Inv. Status: Custom Synthesis

Cat. No: CL-DMTB-NO-05

CAS No: NA

Mol. F: C23H22ClFN6O3

Mol. Wt: 484.911

Inv. Status: Custom Synthesis

Cat. No: CL-DMTB-NO-06

CAS No: NA

Mol. F: C24H24ClFN6O3

Mol. Wt: 498.937

Inv. Status: Custom Synthesis